Article Information
History
- July 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stefania Carobbio1,2,*,†,
- Anne-Claire Guenantin1,2,*,
- Myriam Bahri1,2,
- Isabella Samuelson1,2,
- Floris Honig1,
- Sonia Rodriguez-Fdez1,
- Kathleen Long1,
- Ioannis Kamzolas2,3,
- Sherine Awad2,
- Dunja Lukovic4,
- Slaven Erceg5,
- Andrew Bassett1,
- Sasha Mendjan6,
- Ludovic Vallier7,8,
- Barry S. Rosen1,
- Davide Chiarugi2 and
- Antonio Vidal-Puig1,2,9,†
- 1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK
- 2Metabolic Research Laboratories, Addenbrooke’s Treatment Centre, Institute of Metabolic Science, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK
- 3European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK
- 4Retinal Degeneration Lab and National Stem Cell Bank-Valencia Node, Research Center Principe Felipe, Valencia, Spain
- 5Stem Cell Therapies for Neurodegenerative Diseases Lab and National Stem Cell Bank - Valencia Node, Research Center Principe Felipe, Valencia, Spain
- 6Institute of Molecular Biotechnology, 1030 Vienna. Austria
- 7Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK
- 8Department of Surgery, University of Cambridge, Cambridge, UK
- 9Cambridge University Nanjing Centre of Technology and Innovation, Jiangbei Area, Nanjing, P.R. of China
- ↵†Corresponding authors: Stefania Carobbio, sc22{at}sanger.ac.uk and Antonio Vidal-Puig, ajv22{at}medschl.cam.ac.uk
↵* These authors contributed equally to the work